Michael Burgess actually said...

"We have heard from many stakeholders that the provisions that were put in place have limited FDA's ability."

"We need to reauthorize the user fees by the end of June to assure continuity at the FDA and increase predictability for America's medical innovators and job creators."

"It seems like we could do this if we just had the political will to take it."

"I think that there is a lot of the American electorate, a lot of the American people, feel that simplifying the tax system should be one of our highest priorities."